Lower extremity revascularization via endovascular and surgical approaches: A systematic review with emphasis on combined inflow and outflow revascularization
- PMID: 32551113
- PMCID: PMC7278295
- DOI: 10.1177/2050312120929239
Lower extremity revascularization via endovascular and surgical approaches: A systematic review with emphasis on combined inflow and outflow revascularization
Abstract
This review is intended to help clinicians and patients understand the present state of peripheral artery disease, appreciate the progression and presentation of critical limb ischemia/chronic limb-threatening ischemia, and make informed decisions regarding inflow and outflow endovascular revascularization and surgical treatment options within the context of current debates in the medical community. A controlled literature search was performed to obtain research on outcomes of critical limb ischemia patients undergoing complete leg revascularization for peripheral artery disease inflow and outflow disease. Data for this review were identified by queries of medical and life science databases, expert referral, and references from relevant papers published between 1997 and 2019, resulting in 48 articles. The literature review herein indicates that endovascular revascularization-including ballooning, stenting, and atherectomy-is an effective peripheral artery disease therapy for both above the knee and below the knee disease, and can safely and effectively treat both inflow and outflow disease. As such, it plays a leading role in the therapy of lower extremity artery disease.
Keywords: Peripheral artery disease; critical limb ischemia; limb salvage; revascularization.
© The Author(s) 2020.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: J.A.M. has consulting agreements with Boston Scientific (BSc), Cardiovascular Systems, Inc. (CSI), Bard Peripheral Vascular (BPV), Terumo Medical, and Philips. G.P. is a consultant for CSI. C.W.B. is a lecturer for Penumbra and Cook, and an advisory committee member for BSc. G.A. has consulting agreements with BSc, CSI, Cook Medical, and Abbott Vascular. F.S. has consulting agreements with BSc, CSI, Terumo, BPV, Philips, and Medtronic. B.M.A. and B.J.M. are employees of and hold stock in CSI. M.S.L. and J.R. have no declarations of interest.
Figures
References
-
- Hirsch AT, Duval S. The global pandemic of peripheral artery disease. Lancet 2013; 382: 1312–1314. - PubMed
-
- Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in2000 and 2010: a systematic review and analysis. Lancet 2013; 382: 1329–1340. - PubMed
-
- Peripheral arterial disease (PAD): European population-based action plan for early diagnosis, http://www.euro.who.int/en/health-topics/Life-stages/healthy-ageing/news... (2014, accessed 21 February 2018).
-
- Dominguez A, III, Bahadorani J, Reeves R, et al. Endovascular therapy for critical limb ischemia. Expert Rev Cardiovasc Ther 2015; 13: 429–444. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
